There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
CNN
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage. Liraglutide, sold under the brand name Victoza for diabetes, is an earlier iteration in the same class as semaglutide, the active ingredient in Ozempic. Both are sold by Danish drug giant Novo Nordisk. The generic liraglutide is sold by Hikma Pharmaceuticals USA, and a spokesman told CNN by email that the company expects to make the drug available nationwide before the end of the year. The company didn’t disclose the planned price of the generic, noting only that it “will cost less than branded Victoza.” The branded drug costs between $500 and $815 per package, depending on the dosage, before discounts or insurance, according to Novo Nordisk, which also sells a version of liraglutide approved for obesity, called Saxenda. “There are many people on this drug, and they will benefit by another generic version of it,” Dr. Harlan Krumholz, a cardiologist at Yale University and Yale New Haven Hospital, told CNN by email. But, Krumholz noted, the newer GLP-1 drugs, which are given as weekly injections instead of daily ones, have shown stronger benefits, especially for patients with obesity – and those aren’t yet available as generics.
In an age ruled by neatly slicked buns, it’s easy to forget there was a time before extra-hold gel — when hair was encouraged to expand rather than contract.
President-elect Donald Trump has praised the polio vaccine as the “greatest thing,” but a lawyer affiliated with Trump’s pick to lead the country’s top health agency has petitioned the US Food and Drug Administration to revoke approval of the vaccine used in the United States.
Housing the Met’s modern and contemporary art collection from 2030, the new Oscar L. Tang and H.M. Agnes Hsu-Tang Wing is the first in the museum’s 154-year history to be designed by a female architect.
Robert Eggers’ remake of the horror classic is an all-encompassing psychosexual nightmare — and the bursting bodices only add to the film’s fever pitch.
Most women in the United States haven’t received birth control prescriptions or other family planning services in recent years, a new report suggests, even as abortion restrictions have grown.
Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new draft recommendation from the US Preventive Services Task Force.
The Russian-born, American artist has garnered critical acclaim for her subtle, unnerving images of Florida’s collapsing pastel-pink landscapes.
Thanks to effective and popular new drugs for weight loss and diabetes – an estimated 1 in 8 adults in the US has used Ozempic or a similar GLP-1 medication – demand for procedures to lift and tighten skin has surged.
Pantone has named an “evocative soft brown” called Mocha Mousse its color of the year for 2025.
Anesthesiologists are raising alarm about an insurance company’s plan to limit the amount time they cover for anesthesia used in surgeries and procedures. One major professional group of anesthesiologists is calling for immediate reversal of the “unprecedented move,” saying it’s egregious and uninformed.
British luxury automaker Jaguar has revealed its Type 00 concept car, the first glimpse of a new electric vehicle following a controversial rebrand that has divided opinion on social media.